Delivery Order SPE2DB22D7058-SPE2DB25FSUT1
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,917.62, is for the delivery of Lidocaine HCl 1% Vial 10mL to support military healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,233.85, is for the delivery of Lidocaine HCL 1% Vial 10ML medical supplies. The contract is structured as a Firm Fixed Price Delivery Order and has an ultimate completion date of January 29, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,731.76 firm-fixed-price delivery order is for the supply of 4560703404 - Lidocaine HCL 1% Vial 2ML, with a period of performance through April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of medical products, specifically Lidocaine HCL 2% 200 mg/10 ml, to support military healthcare programs. The contract is a Delivery Order valued at $10,212.03 with a Firm Fixed Price pricing type. It is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corporation (Corporate Office Division) by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The $1,484.79 firm fixed-price contract is for the supply of lidocaine hydrochloride 2% vials, a critical medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,391.46, is for the delivery of 4,567,015,290 units of Lidocaine 1% 20ml 25s. The contract has a completion date of February 20, 2025 and is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award is for the delivery of Lidocaine HCL 1% medical vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $1,366.67, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm-fixed price basis. This is a delivery order contract with a completion date of June 6, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,234.54 firm fixed price contract is for the supply of Lidocaine HCL 4% Solution 4ML, a medication product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award, valued at $1,070.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567130613 - Lidocaine 2% Viscous Solution 100ML, a medical product used in various healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 4, 2025. It is not designated as a...